William Ciambrone
Director/Board Member bei Massachusetts Biotechnology Education Foundation
Vermögen: 1 Mio $ am 31.03.2024
Profil
William F.
Ciambrone is currently the Director at Massachusetts Biotechnology Education Foundation.
Previously, he held the position of Executive Vice President-Technical Operations at Sarepta Therapeutics, Inc. from 2019 to 2022 and at Shire Plc from 2013 to 2015.
He also served as Vice President-Quality at Shire Human Genetic Therapies, Inc. Mr. Ciambrone obtained his undergraduate degree from St. Anselm College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2023 | 8 509 ( 0,01% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von William Ciambrone
| Unternehmen | Position | Beginn |
|---|---|---|
Massachusetts Biotechnology Education Foundation
 Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Ehemalige bekannte Positionen von William Ciambrone
| Unternehmen | Position | Ende |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 31.12.2022 |
| SHIRE | Corporate Officer/Principal | 01.08.2015 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von William Ciambrone
| St. Anselm College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Massachusetts Biotechnology Education Foundation
Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Commercial Services |
